Clinical Trial: Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07591298) titled 'Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia' on May 09.

Brief Summary: This trial is a multicenter, open-label, phase II clinical study, aiming to evaluate the efficacy and safety of SYH2070 injection in participants with HoFH.

Study Start Date: May 24

Study Type: INTERVENTIONAL

Condition: Diagnosed With HoFH

Intervention: DRUG: SYH2070 injection dose1

The patient will receive a treatment period of 48weeks

DRUG: SYH2070 injection dose2

The patient will receive a treatment period of 48weeks

Recruitment Status: NOT_YET_RECRUITIN...